vs
GoodRx Holdings, Inc.（GDRX）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是GoodRx Holdings, Inc.的1.2倍（$225.0M vs $194.8M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs -1.9%），GoodRx Holdings, Inc.自由现金流更多（$31.6M vs $26.2M），过去两年GoodRx Holdings, Inc.的营收复合增速更高（-0.8% vs -12.3%）
GoodRx是一家美国医疗健康企业，运营着远程医疗平台以及可免费使用的网站与移动应用，服务覆盖美国超75000家药店，可为用户追踪处方药价格、提供药品优惠折扣券，还支持用户在线问诊，获取部分品类药物的处方。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
GDRX vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.2倍
$194.8M
营收增速更快
ROCK
高出26.9%
-1.9%
自由现金流更多
GDRX
多$5.4M
$26.2M
两年增速更快
GDRX
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $194.8M | $225.0M |
| 净利润 | $5.4M | — |
| 毛利率 | — | 25.3% |
| 营业利润率 | 11.6% | 7.9% |
| 净利率 | 2.8% | — |
| 营收同比 | -1.9% | 24.9% |
| 净利润同比 | -19.5% | — |
| 每股收益（稀释后） | $0.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDRXROCK
| Q4 25 | $194.8M | $225.0M | ||
| Q3 25 | $196.0M | $310.9M | ||
| Q2 25 | $203.1M | $309.5M | ||
| Q1 25 | $203.0M | $290.0M | ||
| Q4 24 | $198.6M | $180.1M | ||
| Q3 24 | $195.3M | $277.1M | ||
| Q2 24 | $200.6M | $273.6M | ||
| Q1 24 | $197.9M | $292.5M |
净利润GDRXROCK
| Q4 25 | $5.4M | — | ||
| Q3 25 | $1.1M | $-89.1M | ||
| Q2 25 | $12.8M | $26.0M | ||
| Q1 25 | $11.1M | $21.1M | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $4.0M | $34.0M | ||
| Q2 24 | $6.7M | $32.2M | ||
| Q1 24 | $-1.0M | $24.9M |
毛利率GDRXROCK
| Q4 25 | — | 25.3% | ||
| Q3 25 | — | 26.6% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 28.9% |
营业利润率GDRXROCK
| Q4 25 | 11.6% | 7.9% | ||
| Q3 25 | 7.5% | 12.8% | ||
| Q2 25 | 13.2% | 12.8% | ||
| Q1 25 | 11.5% | 8.8% | ||
| Q4 24 | 9.2% | 13.3% | ||
| Q3 24 | 10.5% | 15.6% | ||
| Q2 24 | 9.9% | 14.9% | ||
| Q1 24 | 3.7% | 10.8% |
净利率GDRXROCK
| Q4 25 | 2.8% | — | ||
| Q3 25 | 0.6% | -28.6% | ||
| Q2 25 | 6.3% | 8.4% | ||
| Q1 25 | 5.4% | 7.3% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 2.0% | 12.3% | ||
| Q2 24 | 3.3% | 11.8% | ||
| Q1 24 | -0.5% | 8.5% |
每股收益（稀释后）GDRXROCK
| Q4 25 | $0.02 | — | ||
| Q3 25 | $0.00 | $-2.98 | ||
| Q2 25 | $0.04 | $0.87 | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.01 | $1.11 | ||
| Q2 24 | $0.02 | $1.05 | ||
| Q1 24 | $0.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $261.8M | $115.7M |
| 总债务越低越好 | $495.0M | $0 |
| 股东权益账面价值 | $616.3M | $950.4M |
| 总资产 | $1.4B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.80× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资GDRXROCK
| Q4 25 | $261.8M | $115.7M | ||
| Q3 25 | $273.5M | $89.4M | ||
| Q2 25 | $281.3M | $43.3M | ||
| Q1 25 | $301.0M | $25.1M | ||
| Q4 24 | $448.3M | $269.5M | ||
| Q3 24 | $423.8M | $228.9M | ||
| Q2 24 | $524.9M | $179.1M | ||
| Q1 24 | $533.3M | $146.7M |
总债务GDRXROCK
| Q4 25 | $495.0M | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | $500.0M | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益GDRXROCK
| Q4 25 | $616.3M | $950.4M | ||
| Q3 25 | $600.7M | $951.8M | ||
| Q2 25 | $643.0M | $1.0B | ||
| Q1 25 | $654.3M | $1.0B | ||
| Q4 24 | $724.7M | $1.0B | ||
| Q3 24 | $696.4M | $1.0B | ||
| Q2 24 | $669.4M | $975.7M | ||
| Q1 24 | $631.1M | $940.2M |
总资产GDRXROCK
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.4B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B | ||
| Q1 24 | $1.5B | $1.3B |
负债/权益比GDRXROCK
| Q4 25 | 0.80× | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.69× | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $31.6M | $26.2M |
| 自由现金流率自由现金流/营收 | 16.2% | 11.7% |
| 资本支出强度资本支出/营收 | 0.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 6.06× | — |
| 过去12个月自由现金流最近4个季度 | $164.4M | $120.6M |
8季度趋势，按日历期对齐
经营现金流GDRXROCK
| Q4 25 | $32.9M | $35.5M | ||
| Q3 25 | $76.0M | $73.0M | ||
| Q2 25 | $49.6M | $44.9M | ||
| Q1 25 | $9.4M | $13.7M | ||
| Q4 24 | $44.7M | $19.9M | ||
| Q3 24 | $86.9M | $64.7M | ||
| Q2 24 | $9.7M | $36.5M | ||
| Q1 24 | $42.6M | $53.2M |
自由现金流GDRXROCK
| Q4 25 | $31.6M | $26.2M | ||
| Q3 25 | $74.3M | $64.8M | ||
| Q2 25 | $49.2M | $27.3M | ||
| Q1 25 | $9.3M | $2.3M | ||
| Q4 24 | $44.6M | $14.1M | ||
| Q3 24 | $86.5M | $60.5M | ||
| Q2 24 | $9.4M | $33.5M | ||
| Q1 24 | $42.2M | $48.8M |
自由现金流率GDRXROCK
| Q4 25 | 16.2% | 11.7% | ||
| Q3 25 | 37.9% | 20.8% | ||
| Q2 25 | 24.2% | 8.8% | ||
| Q1 25 | 4.6% | 0.8% | ||
| Q4 24 | 22.4% | 7.8% | ||
| Q3 24 | 44.3% | 21.8% | ||
| Q2 24 | 4.7% | 12.2% | ||
| Q1 24 | 21.3% | 16.7% |
资本支出强度GDRXROCK
| Q4 25 | 0.6% | 4.1% | ||
| Q3 25 | 0.9% | 2.6% | ||
| Q2 25 | 0.2% | 5.7% | ||
| Q1 25 | 0.1% | 3.9% | ||
| Q4 24 | 0.1% | 3.3% | ||
| Q3 24 | 0.2% | 1.5% | ||
| Q2 24 | 0.1% | 1.1% | ||
| Q1 24 | 0.2% | 1.5% |
现金转化率GDRXROCK
| Q4 25 | 6.06× | — | ||
| Q3 25 | 67.94× | — | ||
| Q2 25 | 3.86× | 1.73× | ||
| Q1 25 | 0.85× | 0.65× | ||
| Q4 24 | 6.64× | — | ||
| Q3 24 | 21.91× | 1.90× | ||
| Q2 24 | 1.45× | 1.13× | ||
| Q1 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDRX
| Prescription Transactions Revenue | $124.7M | 64% |
| Other | $44.4M | 23% |
| Subscription Revenue | $21.6M | 11% |
| Other Revenue | $4.1M | 2% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
